Effects of Atorvastatin as Antioxidants in Diabetic associated Cardiovascular Complications

Journal Title: Journal of Pharmaceutical Sciences and Research - Year 2010, Vol 2, Issue 4

Abstract

Oxidative stress is pathogenetic hypotheses of vascular complication in diabetes by impaired endothelial dysfunction (ED) and antioxidant status. The endothelium is complex organ essential for controlling vascular functions. Vascular ED leads to pathogenesis of diabetic associated cardiovascular complications. The aim of present study was to evaluate the role of Atorvastatin in diabetic cardiovascular complications. Atorvastatin, HMG-CoA reductase inhibitors used as lipid lowering began to emerge; such pleiotropic effects include improvement of ED, increased Nitric oxide (NO) bioavailability, antioxidant, anti-inflammatory activities. Hence to evaluate the effect of Atorvastatin in diabetic vascular complications, we studied the effect of Atorvastatin on acetylcholine responses in thoracic aorta isolated from streptozotocin (60 mg/ kg i.p.) induced 8 weeks diabetic rats. Acetylcholine induced relaxation response was significantly decreased in aortic strips from diabetic with compared to control rats. Lipidperoxidation was significantly increased while Superoxide dismutase (SOD) and Catalase activity were significantly decreased in aorta of diabetic rats with compared to control rats. The systolic, diastolic and mean arterial pressure (MAP) was significantly increased in diabetic rats with compared to control rats. Diabetic rats treated with Atorvastain (20 & 40 mg/kg/day) for 8 weeks selectively restored ED relaxation response of acetylcholine to near the reactivity observed in vessels from control rats. The enhanced lipidperoxidation, systolic, diastolic and MAP and reduced SOD and Catalase activity were significantly restored to control values following  Atorvastain treatment. From results we infer that Atorvastain improves diabetes-induced ED by reducing oxidative stress and blood pressure, increasing relaxation responses of acetylcholine. So it could be an ideal intervention in therapy of diabetic associated cardiovascular complications.

Authors and Affiliations

Patel Timir B , Dr. L. D. Patel , Patel Tejas B , Makwana Sunil H , Dr. S. P. Adeshara

Keywords

Related Articles

Microwave assisted synthesis of quinazolinone using different bases

 Microwave assisted organic synthesis (MAOS) has emerged as frontier in pharmaceutical research for synthesis of newer drugs. MAOS help not only in implementing GREEN chemistry but also led to the revoluti...

Spectrophotometric determination of Ceftiofur in pharmaceutical formulations by FGFCF, SFNO and MB

Three simple spectrophotometric methods are proposed for the determination of Ceftiofur (CEFT) in bulk drug and in pharmaceutical preparations. The method is based on oxidation product with Fast green FCF (FGFCF)/KMnO4-,...

ormulation and Evaluation of Clarithromycin Extended Release Tablets

 The Present study to investigate the formulation development of orally administrable Clarithromycin delayed release tablet. Clarithromycin tablet was designed for the delaying the release to prolong the durati...

Optimization of Eudragit RS Microspheres for controlled release of Theophylline using Response Surface Methodology

The present study reports on the production of theophylline loaded Eudragit RS microspheres for controlled release. The microspheres were prepared by the emulsion solvent evaporation technique using Eudragit RS as the p...

Design, Synthesis and Antiinflammatory Activity of Novel gamma Tocopherol Naproxen Ester Prodrug.

 Naproxen is widely used for the treatment of arthritic pain. It can induce gastrointestinal (GI) side effects ranging from stomach irritation to ulceration and bleeding. These complications are believed to be deter...

Download PDF file
  • EP ID EP102594
  • DOI -
  • Views 114
  • Downloads 0

How To Cite

Patel Timir B, Dr. L. D. Patel, Patel Tejas B, Makwana Sunil H, Dr. S. P. Adeshara (2010). Effects of Atorvastatin as Antioxidants in Diabetic associated Cardiovascular Complications. Journal of Pharmaceutical Sciences and Research, 2(4), 247-256. https://europub.co.uk/articles/-A-102594